[PMID: 3782149] PubMed record related to this compound for laboratory literature review
In summary, this compounded injection is contraindicated in anyone with allergies to its components, in neonates, and in patients in whom even moderate doses of B/B might pose unacceptable risks (e.g
Interestingly, a large portion of duplicated genes is enriched in the lignin biosynthesis module of the phenylpropanoid pathway, which could have resulted in the formation of the hard thorns of durian fruits
These can include gastrointestinal issues, skin rashes, or allergic reactions in rare cases
Multiple randomized DBS studies of PD have confirmed symptomatic benefit 65,66,67 , now recommended to within four years of PD disease onset when medically indicated (medication refractory tremor, motor fluctuations, or medication limiting side effects) 68